Results of HLA class II typing in 2020
| Trials | Specimen | Resolution | HLA-DR | No. of labs | HLA-DQ | No. of labs |
|---|---|---|---|---|---|---|
| 1st | IHL-20-01 | Generic type | DRB1*14 | 1 | DQB1*03/DQB1*05 | 45 |
| DRB1*14/Blank | 65 | |||||
| Allelic type | DRB1*14:03/DRB1*14:05 | 25 | DQB1*03:01/DQB1*05:03 | 16 | ||
| DRB1*14:05G/DRB1*14:03 | 3 | DQB1*05:03G/DQB1*03:01G | 1 | |||
| Serological equivalent | DR14/Blank | 22 | DQ5/DQ7 | 45 | ||
| DR14/DR1403 | 44 | |||||
| IHL-20-02 | Generic type | DRB1*04/DRB1*13 | 66 | DQB1*04/DQB1*06 | 45 | |
| Allelic type | DRB1*04:05/DRB1*13:02 | 25 | DQB1*04:01/DQB1*06:04 | 16 | ||
| DRB1*04:05G/DRB1*13:02G | 3 | DQB1*04:01G/DQB1*06:04G | 1 | |||
| Serological equivalent | DR4/DR13 | 66 | DQ4/DQ6 | 45 | ||
| 2nd | IHL-20-03 | Generic type | DRB1*14 | 3 | DQB1*03 | 2 |
| DRB1*14/Blank | 64 | DQB1*03/Blank | 45 | |||
| Allelic type | DRB1*14:06/DRB1*14:06 | 4 | DQB1*03:01/DQB1*03:01 | 2 | ||
| DRB1*14:06/DRB1*99:99 | 24 | DQB1*03:01/DQB1*99:99 | 14 | |||
| DQB1*03:01G/DQB1*03:01G | 2 | |||||
| Serological equivalent | DR14 | 3 | DQ7 | 2 | ||
| DR14/Blank | 64 | DQ7/Blank | 45 | |||
| IHL-20-04 | Generic type | DRB1*04/DRB1*08 | 67 | DQB1*04/DQB1*06 | 47 | |
| Allelic type | DRB1*04:05/DRB1*08:03 | 25 | DQB1*04:01/DQB1*06:01 | 16 | ||
| DRB1*04:05G/DRB1*08:03G | 3 | DQB1*04:01/DQB1*06:01G | 2 | |||
| Serological equivalent | DR4/DR8 | 67 | DQ4/DQ6 | 47 |
Bold letter indicates the results which are not compliant with the intended responses.
Abbreviation: HLA, human leukocyte antigen.